Laboratory studies have continued to investigate its role in sleep-wake cycle regulation and its interactions with endogenous sleep-promoting systems
OctoberDecember 2025: imlunestrant Imlunestrant, a next-generation, brain-penetrant, oral selective estrogen receptor degrader (SERD) by Eli Lilly, is awaiting FDA approval for patients with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer
Constant stress pumps out cortisol that encourages fat storage
A randomized, double-blind, placebo-controlled trial (2022) showed that just 2g/day of spirulina for three months significantly reduced HbA1c and fasting blood sugar in type 2 diabetic patients the downstream effects youd expect from enhanced GLP-1 activity
Approximately 70% of high-dose participants achieved 5% weight loss, with 48% reaching 10% reduction (Gadde et al., Lancet, 2011)